Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Based on the category tagging and creator context, this video likely runs through some version of the peptide therapy greatest-hits list: BPC-157 for gut healing and injury recovery, TB-500 for tissue repair, CJC-1295 and ipamorelin as a growth hormone-stimulating stack, GHK-Cu for skin regeneration, and MK-677 as an oral growth hormone secretagogue. Creators in this space routinely frame peptides as a cleaner, smarter alternative to steroids or pharmaceutical drugs, positioning them as tools for accelerated recovery, anti-aging, and body composition improvement. The language tends toward personal anecdote with a veneer of biochemistry, citing mechanism of action in ways that sound scientific but quietly skip over the part where most of the supporting data comes from rodent studies or small, non-randomized human trials. Whether this creator takes that approach is speculation until we have the transcript, but the category signals are consistent with that pattern.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and the evidence quality varies enormously. BPC-157 has shown accelerated tendon healing and gastroprotective effects in rat models (Sikiric et al., 2018, Current Pharmaceutical Design), but zero completed randomized controlled trials in humans as of this writing. TB-500, a synthetic fragment of thymosin beta-4, demonstrated some cardiac repair signaling in animal models (Bock-Marquette et al., 2004, Nature), but again, human trial data is essentially nonexistent. CJC-1295 combined with ipamorelin does produce measurable increases in IGF-1 in humans: one trial showed IGF-1 increases of roughly 28-39% over 28 days at doses of 30-60 mcg/kg (Ionescu and Frohman, 2006, Journal of Clinical Endocrinology and Metabolism), which sounds significant until you ask what the clinical outcome actually is. MK-677 is not technically a peptide but gets lumped into this category repeatedly, and it does raise GH pulse amplitude, though a 2022 Lancet Healthy Longevity study found it did not improve muscle function in older adults at 25mg daily over two years.

Where does the social media noise diverge from clinical reality?

The biggest divergence is between mechanism plausibility and clinical proof. A peptide binding to a receptor in a way that theoretically should promote healing is not the same as evidence that injecting it into a human produces the claimed outcome. Creators routinely conflate these. The second major issue is regulatory status. BPC-157, TB-500, and most of these compounds are not FDA-approved for human use. They are sold as research chemicals, compounded in facilities with variable quality control, and the dose consistency between batches is not guaranteed. A 2021 analysis of compounded peptides by the Alliance for Pharmacy Compounding flagged significant potency variability. Third, the side effect discussion is almost always superficial. CJC-1295 can cause water retention, increased fasting glucose, and theoretical long-term IGF-1 elevation risks that nobody in these videos wants to talk about because it undercuts the selling point.

What should you actually know?

Some of these peptides are genuinely interesting from a research standpoint. GHK-Cu has real human data supporting topical wound healing and some skin remodeling effects (Pickart et al., 2015, Journal of Aging Science), and that data is reasonably solid for topical application specifically. Semax and selank have been studied in Russian clinical literature for cognitive and anxiolytic effects, though Western peer-reviewed replication is sparse and those studies rarely meet modern trial design standards. The practical reality for a consumer watching a TikTok is that you are evaluating compounds with incomplete human safety profiles, sourced from a largely unregulated supply chain, based on a creator's personal experience. That is a meaningful risk. If you are genuinely interested in peptide therapy, the appropriate path is a clinical evaluation through a licensed provider who can assess your baseline IGF-1, metabolic markers, and health history before any of this enters the conversation.